Live Analyst Rating Changes 4914 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Mark Jordan
NF
Mark Jordan
Noble Financial
Wall Street Analyst
★★★☆☆
#1767
on 13Foresight · ranked by our own returns
45%
Success Rate
+6.2%
Average Return
9 of 20 calls profitable · -5.8% vs benchmark
📈 Across the calls we could measure, roughly 45% of Mark Jordan's ratings turned a profit when each position was held for 1 year — averaging +6.2% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

0 Buy 0 Hold 2 Sell
Mark's Stock Coverage 20 ratings · 2026-07-03
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
VVV
Valvoline
 Jun 03, 2025 BUY Strong Buy
+3.0% avg upside
26 analysts
$45.00
15.08% Upside
 -5.5%
DRVN
Driven Brands Holdings
 Jun 03, 2025 HOLD Strong Buy
+30.3% avg upside
20 analysts
$20.00
38.22% Upside
 -27.6%
TSE:BYD
Boyd Group Services
 Jun 03, 2025 HOLD Strong Buy
+72.7% avg upside
19 analysts
$231.00
67.90% Upside
 ·
LAD
Lithia Motors
 Jun 03, 2025 HOLD Strong Buy
+12.9% avg upside
27 analysts
$340.00
11.08% Upside
 -8.5%
CACI
Caci International
 Oct 18, 2018 HOLD Buy
-14.4% avg upside
28 analysts
 — +24.4%
CVU
CPI Aerostructures
 Apr 19, 2018 HOLD Buy
+21.9% avg upside
5 analysts
 — -37.9%
KTOS
Kratos Defense
 Apr 18, 2018 BUY Strong Buy
+64.1% avg upside
25 analysts
 — +27.3%
DCO
Ducommun
 Mar 22, 2018 HOLD Strong Buy
-22.3% avg upside
8 analysts
 — +50.9%
AIR
AAR
 Mar 21, 2018 BUY Strong Buy
-13.6% avg upside
10 analysts
 — -22.4%
CMTL
Comtech Telecommunications
 Mar 09, 2018 BUY Strong Buy
+1143.5% avg upside
10 analysts
$33.50
1635.82% Upside
 -21.8%
ICFI
Icf International
 Feb 28, 2018 HOLD Strong Buy
+28.0% avg upside
11 analysts
 — +33.6%
DLHC
DLH Holdings
 Feb 07, 2018 BUY Strong Buy
+98.0% avg upside
4 analysts
 — -15.4%
MRCY
Mercury Systems
 Jan 24, 2018 HOLD Strong Buy
-36.7% avg upside
14 analysts
 — +2.4%
INOD
Innodata
 Dec 06, 2017 HOLD Strong Buy
+78.2% avg upside
8 analysts
 — +50.5%
III
Information Services Group
 Nov 13, 2017 BUY Strong Buy
+97.6% avg upside
8 analysts
 — +4.9%
HRTX
Heron Therapeutics
 Aug 10, 2017 BUY Strong Buy
+6142.2% avg upside
21 analysts
 — +148.1%
CRBP
Corbus Pharmaceuticals
 Aug 09, 2017 BUY Strong Buy
+283.7% avg upside
20 analysts
 — -20.7%
AVXL
Anavex Life Sciences
 Aug 08, 2017 BUY Strong Buy
+781.0% avg upside
9 analysts
 — -22.5%
ASYS
Amtech Systems
 Feb 05, 2016 HOLD Hold
-28.9% avg upside
6 analysts
 — +6.0%
NTCT
Netscout Systems
 Oct 14, 2014 SELL Hold
-24.3% avg upside
7 analysts
$38.00
7.14% Downside
 -15.5%
🔒 15 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Mark Jordan — Frequently Asked Questions
How accurate are Mark Jordan's stock ratings?
Based on the calls 13Foresight could measure, about 45% of Mark's ratings were profitable over a one-year hold, with an average return of +6.2% per rating, or -5.8% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Mark ranked on 13Foresight?
Mark Jordan is currently ranked #1767 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Mark cover?
Mark most recently has ratings on VVV, DRVN, TSE:BYD, LAD, CACI, CVU, KTOS, DCO, AIR, CMTL, ICFI, DLHC and 8 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.